Humalog kwikpen side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Humalog kwikpen (insulin lispro recombinant). Common side effects include blood glucose increased among females and blood glucose increased among males.
The phase IV clinical study is created by eHealthMe based on 3,425 reports from the FDA, and is updated regularly.
What is Humalog Kwikpen?
Humalog kwikpen has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 3,512 Humalog kwikpen users. Check the latest studies of Humalog kwikpen.
3,425 people who take Humalog Kwikpen and have side effects are studied.
What are the common side effects of Humalog kwikpen, by gender? *
What are the common side effects of Humalog kwikpen, by age (0-1 to 60+)? *
What are the common side effects of Humalog kwikpen, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Humalog kwikpen?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on insulin lispro recombinant (the active ingredients of Humalog kwikpen) and Humalog kwikpen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Humalog kwikpen:
- Humalog kwikpen (3,512 reports)
All Humalog kwikpen side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Plaquenil and Magnesium drug interactions for women aged 20-29 - a second ago
- Could Isoniazid cause Consciousness - Decreased? - 6 seconds ago
- Drug interactions of Morphine and Imodium - 7 seconds ago
- Drug interactions of Fentanyl Transdermal System and Hydramine - 14 seconds ago
- Valsartan and Ms for Men aged 60+ - 19 seconds ago
- Could Fentanyl Citrate cause Mydriasis? - 19 seconds ago
- Valsartan and Ms Hug for Men aged 60+ - 20 seconds ago
- Valsartan and Multiple Sclerosis for Men aged 60+ - 20 seconds ago
- Could Humira cause T-Cell Lymphoma? - 20 seconds ago
- Drug interactions of Acitretin and Carbamazepine - 21 seconds ago